Paragon Genomics

Paragon Genomics develops and commercializes rapid, easy-to-use, ultra-high multiplex PCR-based target enrichment solutions for Next-Generation Sequencing (NGS). Their proprietary CleanPlex® background-removing technology enables NGS customers to develop targeted sequencing assays that are accurate, sensitive, and simple, yet cost effective. Their technology is applicable to many fast-growing NGS segments such as cancer research, liquid biopsy, biomarker discovery, genomics-guided breeding, companion diagnostics, and immunotherapy monitoring.

Bio-Connect supplies all their products in the Benelux. If you have any questions, please contact the helpdesk.

Major product lines from Paragon Genomics

• Targeted CleanPlex Panels for Oncology
• Targeted CleanPlex UMI Panels for 0.1% variant detection
• Omni and AccuFusion Panels for known and unknown fusion detection
• NGS Research Panels for infectious diseases
• Custom Designed Targeted Panels for a variety of applications in cancer, pharmacogenetics, infectious disease, agrigenomics, and more.